Dianthus Therapeutics, Inc.
NasdaqCM DNTH
Dianthus Therapeutics, Inc. Share Price on January 14, 2025: USD 19.88
Dianthus Therapeutics, Inc. Share Price is USD 19.88 on January 14, 2025, a 62.29% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.
-
Dianthus Therapeutics, Inc. 52-week high Share Price is USD 31.94 on March 22, 2024, which is 60.66% above the current Share Price.
-
Dianthus Therapeutics, Inc. 52-week low Share Price is USD 11.50 on January 18, 2024, which is -42.15% below the current Share Price.
-
Dianthus Therapeutics, Inc. average Share Price for the last 52 weeks is USD 25.29.
Key data
| Date | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) |
|---|
Market news
Loading...
NasdaqCM: DNTH
| CEO | Mr. Marino Garcia M.B.A. |
| IPO Date | June 21, 2018 |
| Location | United States |
| Headquarters | 7 Times Square |
| Employees | 53 |
| Sector | Health Care |
| Industries | |
Description
Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. It develops DNTH103 that is in phase 1 clinical trails in patients with generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was incorporated in 2015 and is based in New York, New York.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email